Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

442 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Results of a salvage regimen in refractory or relapsed non-Hodgkin's lymphoma.
Buzzoni R, Colleoni M, Nelli P, Nolè F, Bajetta E. Buzzoni R, et al. Among authors: colleoni m. Leuk Lymphoma. 1994 Jun;14(1-2):121-8. doi: 10.3109/10428199409049657. Leuk Lymphoma. 1994. PMID: 7920218 Clinical Trial.
Phase-ii trial of oral doxifluridine plus oral levo-leucovorin in unresectable hepatocellular-carcinoma.
Colleoni M, Dibartolomeo M, Bajetta E, Nole F, Nelli P, Carnaghi C, Vicario G, Delvecchio M, Bono A. Colleoni M, et al. Oncol Rep. 1995 Jul;2(4):603-6. doi: 10.3892/or.2.4.603. Oncol Rep. 1995. PMID: 21597785
Therefore, we evaluated the activity and feasibility of a combination of dFUR and l-leucovorin in unresectable HCC by the following schedule: l-leucovorin 25 mg orally followed 2 hours later by dFUR 1,200 mg/m(2), day 1 through 5, cycles being repeated every 10 days. ...
Therefore, we evaluated the activity and feasibility of a combination of dFUR and l-leucovorin in unresectable HCC by the following schedule …
Prediction of response to primary chemotherapy for operable breast cancer.
Colleoni M, Orvieto E, Nolé F, Orlando L, Minchella I, Viale G, Peruzzotti G, Robertson C, Noberasco C, Galimberti V, Sacchini V, Veronesi P, Zurrida S, Orecchia R, Goldhirsch A. Colleoni M, et al. Eur J Cancer. 1999 Apr;35(4):574-9. doi: 10.1016/s0959-8049(99)00005-2. Eur J Cancer. 1999. PMID: 10492630
Systemic treatments for women with breast cancer: outcome with relation to screening for the disease.
Goldhirsch A, Colleoni M, Domenighetti G, Gelber RD. Goldhirsch A, et al. Among authors: colleoni m. Ann Oncol. 2003 Aug;14(8):1212-4. doi: 10.1093/annonc/mdg327. Ann Oncol. 2003. PMID: 12881381 Review.
Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer.
Colleoni M, Gelber S, Coates AS, Castiglione-Gertsch M, Gelber RD, Price K, Rudenstam CM, Lindtner J, Collins J, Thürlimann B, Holmberg SB, Cortes-Funes H, Simoncini E, Murray E, Fey M, Goldhirsch A; International Breast Cancer Study Group. Colleoni M, et al. J Clin Oncol. 2001 Nov 1;19(21):4141-9. doi: 10.1200/JCO.2001.19.21.4141. J Clin Oncol. 2001. PMID: 11689582 Clinical Trial.
Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors.
Colleoni M, Minchella I, Mazzarol G, Nolè F, Peruzzotti G, Rocca A, Viale G, Orlando L, Ferretti G, Curigliano G, Veronesi P, Intra M, Goldhirsch A. Colleoni M, et al. Ann Oncol. 2000 Aug;11(8):1057-9. doi: 10.1023/a:1008334404825. Ann Oncol. 2000. PMID: 11038046
Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: are all CMFs alike? The International Breast Cancer Study Group (IBCSG).
Goldhirsch A, Colleoni M, Coates AS, Castiglione-Gertsch M, Gelber RD. Goldhirsch A, et al. Among authors: colleoni m. Ann Oncol. 1998 May;9(5):489-93. doi: 10.1023/a:1008236502420. Ann Oncol. 1998. PMID: 9653488 Review.
The first reported effective adjuvant combination regimen for patients with operable breast cancer comprised oral cyclophosphamide (C) days 1-14 with intravenous methotrexate (M) and fluorouracil (F) on days 1 and 8, repeated every 28 days ('classical' CMF). ...
The first reported effective adjuvant combination regimen for patients with operable breast cancer comprised oral cyclophosphamide (C) days …
Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study Group.
Goldhirsch A, Coates AS, Colleoni M, Castiglione-Gertsch M, Gelber RD. Goldhirsch A, et al. Among authors: colleoni m. J Clin Oncol. 1998 Apr;16(4):1358-62. doi: 10.1200/JCO.1998.16.4.1358. J Clin Oncol. 1998. PMID: 9552037 Review.
Mitomycin C and vinorelbine in pretreated breast cancer.
Colleoni M, Manente P, Stocker J, Amor H, Lamon S, Nelli P, Vicario G, Sgarbossa G, Graiff C. Colleoni M, et al. Tumori. 1997 Sep-Oct;83(5):834-6. Tumori. 1997. PMID: 9428918
Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimen.
Orlando L, Colleoni M, Curigliano G, Nolè F, Ferretti G, Masci G, Peruzzotti G, Minchella I, Intra M, Veronesi P, Viale G, Goldhirsch A. Orlando L, et al. Among authors: colleoni m. Anticancer Res. 2001 Nov-Dec;21(6A):4135-9. Anticancer Res. 2001. PMID: 11911307 Clinical Trial.
442 results
Jump to page
Feedback